This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07534/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07534/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07534/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07534/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07534/identifier/chemspider/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07534
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB07534 n12:DB07534
dcterms:title
4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE
adms:identifier
n9:99444005 n10:C85 n11:5729339 n13:4662870 n14:DB07534
n4:IUPAC-Name
n5:271B4DC4-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4DCA-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4DC9-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4DC6-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4DC7-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4DC8-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B4DC2-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4DC0-363D-11E5-9242-09173F13E4C5 n5:271B4DC3-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4DC1-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4DD0-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4DD1-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4DCB-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4DCC-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4DCE-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4DCD-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4DCF-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4DD6-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4DD8-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4DD9-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4DD5-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4DD4-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4DD7-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B4DC5-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4DD2-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4DD3-363D-11E5-9242-09173F13E4C5